AU Stock MarketDetailed Quotes

IMC Immuron Ltd

Watchlist
  • 0.078
  • 0.0000.00%
20min DelayNot Open Dec 20 13:08 AET
17.78MMarket Cap-2.60P/E (Static)

About Immuron Ltd Company

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Company Profile

SymbolIMC
Company NameImmuron Ltd
Founded1994
MarketASX
Employees7
Fiscal Year Ends06-30
AddressChapman Street Unit 10, 25-37
CityMelbourne
CountryAustralia
Zip Code3130
Phone+61 398245254
Websitehttps://www.immuron.com.au
Share RegistryAUTOMIC REGISTRY SERVICES Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000 02 9698 5414

Company Executives

  • Name
  • Position
  • Salary
  • Steven Lydeamore
  • Chief Executive Officer
  • 599.14K
  • Phillip A. Hains
  • Chief Financial Officer and Secretary
  • --
  • Flavio Palumbo
  • Chief Commercial Officer
  • 347.61K
  • Dr. Jerry Kanellos, PhD
  • Chief Scientific Officer
  • 359.25K
  • Paul Brennan
  • Chairman of the Board
  • 153.60K
  • Dr. Jeannette Joughin
  • Independent Director
  • 7.55K
  • Professor Ravi Savarirayan
  • Independent Director
  • 75.00K
  • Daniel Pollock
  • Independent Director
  • 127.65K
Heat List
AU
Overall
Symbol
Price
% Chg

No Data